| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 29 | 2024 | 474 | 6.970 |
Why?
|
| RNA-Binding Protein FUS | 14 | 2023 | 50 | 5.790 |
Why?
|
| Mutation | 19 | 2024 | 2443 | 1.720 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2024 | 135 | 1.720 |
Why?
|
| Nuclear Pore Complex Proteins | 2 | 2023 | 26 | 1.570 |
Why?
|
| Neurodegenerative Diseases | 4 | 2024 | 127 | 1.570 |
Why?
|
| Profilins | 4 | 2024 | 45 | 1.540 |
Why?
|
| Frontotemporal Dementia | 6 | 2023 | 126 | 1.500 |
Why?
|
| Superoxide Dismutase | 7 | 2022 | 213 | 1.490 |
Why?
|
| Motor Neurons | 7 | 2022 | 206 | 1.390 |
Why?
|
| Stress, Physiological | 3 | 2019 | 186 | 1.350 |
Why?
|
| Brain Injuries, Traumatic | 4 | 2023 | 77 | 1.300 |
Why?
|
| Cytoplasmic Granules | 4 | 2019 | 53 | 1.150 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2023 | 106 | 1.090 |
Why?
|
| Neurons | 10 | 2023 | 859 | 1.040 |
Why?
|
| Superoxide Dismutase-1 | 9 | 2022 | 134 | 1.000 |
Why?
|
| Microglia | 3 | 2024 | 227 | 0.930 |
Why?
|
| Skull | 1 | 2023 | 57 | 0.840 |
Why?
|
| Single-Domain Antibodies | 1 | 2022 | 16 | 0.830 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2023 | 83 | 0.820 |
Why?
|
| Protein Folding | 9 | 2022 | 256 | 0.810 |
Why?
|
| Polymerization | 1 | 2021 | 35 | 0.750 |
Why?
|
| Axonal Transport | 3 | 2017 | 31 | 0.740 |
Why?
|
| Actins | 2 | 2021 | 260 | 0.690 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 669 | 0.660 |
Why?
|
| Golgi Apparatus | 1 | 2019 | 64 | 0.650 |
Why?
|
| Receptors, AMPA | 1 | 2019 | 41 | 0.640 |
Why?
|
| Animals | 26 | 2023 | 19663 | 0.640 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 125 | 0.640 |
Why?
|
| Glutamic Acid | 1 | 2019 | 98 | 0.630 |
Why?
|
| Cell Nucleus | 4 | 2019 | 603 | 0.620 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 167 | 0.600 |
Why?
|
| Mice | 19 | 2023 | 10280 | 0.580 |
Why?
|
| Humans | 41 | 2024 | 59526 | 0.570 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 293 | 0.560 |
Why?
|
| Proteostasis Deficiencies | 2 | 2021 | 6 | 0.550 |
Why?
|
| Cyclophilin A | 2 | 2010 | 36 | 0.550 |
Why?
|
| Oxidative Stress | 4 | 2013 | 281 | 0.530 |
Why?
|
| Calcium | 2 | 2019 | 556 | 0.520 |
Why?
|
| Cells | 1 | 2014 | 30 | 0.470 |
Why?
|
| Cytoplasm | 5 | 2023 | 273 | 0.460 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1470 | 0.450 |
Why?
|
| Hypertonic Solutions | 1 | 2013 | 5 | 0.450 |
Why?
|
| Epitopes | 1 | 2014 | 298 | 0.430 |
Why?
|
| DNA Repair | 1 | 2014 | 233 | 0.400 |
Why?
|
| Cell Line | 6 | 2018 | 2015 | 0.400 |
Why?
|
| Mutant Proteins | 4 | 2021 | 105 | 0.390 |
Why?
|
| HIV-1 | 2 | 2010 | 708 | 0.370 |
Why?
|
| Autoantibodies | 1 | 2011 | 175 | 0.360 |
Why?
|
| Brain | 7 | 2023 | 1489 | 0.350 |
Why?
|
| Cell Proliferation | 1 | 2014 | 945 | 0.350 |
Why?
|
| Capsid Proteins | 1 | 2010 | 94 | 0.330 |
Why?
|
| Spinal Cord | 5 | 2018 | 197 | 0.320 |
Why?
|
| Protein Conformation | 5 | 2015 | 766 | 0.300 |
Why?
|
| C9orf72 Protein | 3 | 2023 | 98 | 0.290 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 307 | 0.280 |
Why?
|
| alpha-Synuclein | 2 | 2006 | 20 | 0.280 |
Why?
|
| Oxidation-Reduction | 5 | 2018 | 305 | 0.270 |
Why?
|
| HeLa Cells | 2 | 2021 | 527 | 0.270 |
Why?
|
| Lewy Body Disease | 1 | 2006 | 7 | 0.260 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2019 | 87 | 0.260 |
Why?
|
| Cholesterol | 2 | 2006 | 255 | 0.250 |
Why?
|
| Proteomics | 2 | 2019 | 252 | 0.240 |
Why?
|
| Crystallography, X-Ray | 3 | 2015 | 422 | 0.240 |
Why?
|
| Pick Disease of the Brain | 1 | 2023 | 5 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 2069 | 0.220 |
Why?
|
| Models, Molecular | 6 | 2012 | 1125 | 0.220 |
Why?
|
| Intravital Microscopy | 1 | 2023 | 12 | 0.220 |
Why?
|
| Brain Concussion | 1 | 2023 | 28 | 0.220 |
Why?
|
| Proteins | 3 | 2015 | 740 | 0.220 |
Why?
|
| Cysteine | 2 | 2014 | 108 | 0.210 |
Why?
|
| Neuronal Outgrowth | 1 | 2022 | 10 | 0.210 |
Why?
|
| Coloring Agents | 1 | 2023 | 54 | 0.210 |
Why?
|
| Mass Spectrometry | 3 | 2014 | 286 | 0.210 |
Why?
|
| Cytophagocytosis | 1 | 2022 | 2 | 0.210 |
Why?
|
| Head | 1 | 2023 | 52 | 0.210 |
Why?
|
| Synaptosomes | 1 | 2022 | 16 | 0.210 |
Why?
|
| Chronic Traumatic Encephalopathy | 1 | 2021 | 5 | 0.190 |
Why?
|
| Recombinant Proteins | 3 | 2014 | 694 | 0.190 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2021 | 21 | 0.190 |
Why?
|
| Tauopathies | 1 | 2021 | 15 | 0.190 |
Why?
|
| Capsid | 1 | 2002 | 88 | 0.190 |
Why?
|
| Phagocytosis | 1 | 2022 | 252 | 0.180 |
Why?
|
| DNA Repeat Expansion | 2 | 2023 | 53 | 0.180 |
Why?
|
| Superoxides | 1 | 2020 | 69 | 0.180 |
Why?
|
| Animals, Genetically Modified | 1 | 2021 | 281 | 0.180 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1295 | 0.170 |
Why?
|
| Decapodiformes | 2 | 2017 | 14 | 0.170 |
Why?
|
| Coat Protein Complex I | 1 | 2019 | 5 | 0.170 |
Why?
|
| Arsenites | 1 | 2019 | 7 | 0.170 |
Why?
|
| Weight Loss | 1 | 2021 | 260 | 0.160 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 21 | 0.160 |
Why?
|
| Mutation, Missense | 2 | 2010 | 179 | 0.160 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2010 | 110 | 0.150 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 38 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 324 | 0.150 |
Why?
|
| Drosophila | 1 | 2021 | 420 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 675 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 663 | 0.150 |
Why?
|
| Phenotype | 1 | 2021 | 1157 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1373 | 0.140 |
Why?
|
| Male | 10 | 2023 | 27578 | 0.140 |
Why?
|
| Protein Binding | 3 | 2014 | 1551 | 0.130 |
Why?
|
| Isoenzymes | 2 | 2014 | 133 | 0.130 |
Why?
|
| Kinetics | 3 | 2010 | 733 | 0.130 |
Why?
|
| Astrocytes | 3 | 2022 | 116 | 0.130 |
Why?
|
| Dipeptides | 1 | 2015 | 62 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 201 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2014 | 255 | 0.120 |
Why?
|
| Phosphorylation | 2 | 2014 | 861 | 0.120 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2014 | 5 | 0.120 |
Why?
|
| Hybridomas | 1 | 2014 | 65 | 0.120 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 75 | 0.120 |
Why?
|
| Gene Expression | 2 | 2014 | 810 | 0.120 |
Why?
|
| Genetic Association Studies | 2 | 2014 | 118 | 0.120 |
Why?
|
| Escherichia coli | 2 | 2014 | 685 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 193 | 0.110 |
Why?
|
| In Vitro Techniques | 2 | 2015 | 475 | 0.110 |
Why?
|
| Sorbitol | 1 | 2013 | 2 | 0.110 |
Why?
|
| Protein Structure, Secondary | 1 | 2014 | 249 | 0.110 |
Why?
|
| Methylation | 1 | 2013 | 126 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 357 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 219 | 0.110 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 68 | 0.100 |
Why?
|
| Cell Death | 1 | 2013 | 268 | 0.100 |
Why?
|
| Autophagy | 1 | 2014 | 205 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2013 | 595 | 0.100 |
Why?
|
| Survival | 1 | 2011 | 12 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 1221 | 0.100 |
Why?
|
| Middle Aged | 4 | 2018 | 16279 | 0.100 |
Why?
|
| Adult | 4 | 2018 | 15791 | 0.100 |
Why?
|
| Transduction, Genetic | 1 | 2013 | 233 | 0.100 |
Why?
|
| Cell Survival | 1 | 2013 | 557 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2013 | 577 | 0.090 |
Why?
|
| Histones | 1 | 2014 | 463 | 0.090 |
Why?
|
| RNA Interference | 1 | 2014 | 590 | 0.090 |
Why?
|
| Female | 7 | 2023 | 30924 | 0.090 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 34 | 0.090 |
Why?
|
| Amino Acid Sequence | 5 | 2013 | 1582 | 0.090 |
Why?
|
| Epitope Mapping | 1 | 2010 | 47 | 0.090 |
Why?
|
| Models, Biological | 3 | 2010 | 1142 | 0.090 |
Why?
|
| Esterases | 1 | 2010 | 13 | 0.090 |
Why?
|
| Aryldialkylphosphatase | 1 | 2010 | 19 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 874 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2010 | 184 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2010 | 321 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2011 | 187 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2011 | 295 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 3195 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2009 | 26 | 0.080 |
Why?
|
| Hydrogen Bonding | 1 | 2009 | 125 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 354 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 324 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 851 | 0.080 |
Why?
|
| Axons | 2 | 2023 | 120 | 0.080 |
Why?
|
| Zebrafish | 1 | 2010 | 323 | 0.070 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2007 | 19 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 419 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 530 | 0.070 |
Why?
|
| Catalysis | 2 | 2007 | 154 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 253 | 0.060 |
Why?
|
| Dopamine | 1 | 2006 | 102 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 2015 | 253 | 0.050 |
Why?
|
| Biological Assay | 1 | 2022 | 54 | 0.050 |
Why?
|
| Polyphosphates | 1 | 2022 | 12 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2002 | 68 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 50 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2014 | 255 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 1131 | 0.050 |
Why?
|
| Reflex | 1 | 2021 | 28 | 0.050 |
Why?
|
| Virulence | 1 | 2002 | 189 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2002 | 133 | 0.050 |
Why?
|
| Head Injuries, Closed | 1 | 2021 | 14 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 293 | 0.050 |
Why?
|
| Cations, Monovalent | 1 | 2000 | 1 | 0.040 |
Why?
|
| IMP Dehydrogenase | 1 | 2000 | 2 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 195 | 0.040 |
Why?
|
| Aged | 2 | 2018 | 13346 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2104 | 0.040 |
Why?
|
| Tunicamycin | 1 | 2018 | 8 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2023 | 1989 | 0.040 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 17 | 0.040 |
Why?
|
| Proteostasis | 1 | 2018 | 10 | 0.040 |
Why?
|
| RNA | 2 | 2014 | 404 | 0.040 |
Why?
|
| Transfection | 1 | 2020 | 674 | 0.040 |
Why?
|
| Time Factors | 1 | 2006 | 3579 | 0.040 |
Why?
|
| Peptides | 1 | 2002 | 549 | 0.040 |
Why?
|
| Tryptophan | 1 | 2018 | 55 | 0.040 |
Why?
|
| Gene Editing | 1 | 2022 | 301 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 502 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1979 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 55 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1538 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2002 | 813 | 0.030 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2015 | 19 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1044 | 0.030 |
Why?
|
| Disulfides | 1 | 2014 | 62 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 642 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 74 | 0.030 |
Why?
|
| Artifacts | 1 | 2014 | 126 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 420 | 0.030 |
Why?
|
| Jews | 1 | 2012 | 14 | 0.030 |
Why?
|
| Growth Cones | 1 | 2012 | 14 | 0.030 |
Why?
|
| Aging | 1 | 2018 | 723 | 0.030 |
Why?
|
| Exome | 1 | 2012 | 73 | 0.030 |
Why?
|
| Pedigree | 1 | 2012 | 190 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 106 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 308 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1518 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 848 | 0.020 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2011 | 17 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 250 | 0.020 |
Why?
|
| RNA Helicases | 1 | 2011 | 88 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 618 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 111 | 0.020 |
Why?
|
| tau Proteins | 1 | 2009 | 104 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2009 | 194 | 0.020 |
Why?
|
| Age of Onset | 1 | 2009 | 172 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2011 | 367 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 5092 | 0.020 |
Why?
|
| Family | 1 | 2010 | 220 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2009 | 376 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 253 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 193 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 1313 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2009 | 158 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 189 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2009 | 249 | 0.020 |
Why?
|
| Synapses | 1 | 2009 | 177 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 397 | 0.020 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2007 | 3 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2007 | 11 | 0.020 |
Why?
|
| Titrimetry | 1 | 2007 | 11 | 0.020 |
Why?
|
| Aldehydes | 1 | 2006 | 16 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2007 | 133 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 64 | 0.020 |
Why?
|
| Amyloid | 1 | 2006 | 62 | 0.020 |
Why?
|
| Biopolymers | 1 | 2006 | 69 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2006 | 147 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 551 | 0.010 |
Why?
|
| Inosine Monophosphate | 1 | 2000 | 1 | 0.010 |
Why?
|
| Lithium | 1 | 2000 | 13 | 0.010 |
Why?
|
| Sodium | 1 | 2000 | 60 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 102 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 1102 | 0.010 |
Why?
|
| NAD | 1 | 2000 | 48 | 0.010 |
Why?
|
| Magnesium | 1 | 2000 | 58 | 0.010 |
Why?
|
| Potassium | 1 | 2000 | 109 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2009 | 2891 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 353 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 809 | 0.010 |
Why?
|
| Binding Sites | 1 | 2000 | 875 | 0.010 |
Why?
|